Diabetes Mellitus(ISSN:2072-0351)

Chronic kidney disease in type 2 diabetes: trends in prevalence, clinical phenotypes and outcomes

Type 2 diabetes mellitus (T2DM) is one of the leading causes of chronic kidney disease (CKD). This review analyzes the results of studies assessing the prevalence, clinical phenotypes, and outcomes of CKD in T2DM. Over the past 20–30 years, there has been a global trend toward an increase in the number of patients with T2DM and CKD. At the same time, the prevalence of CKD among patients w

Lower extremity limb salvage in diabetic patients: the impossible is possible

Lesions of the lower extremities in diabetes mellitus are a complex and urgent problem of modern medicine. The high prevalence of diabetes mellitus, significant difficulties in timely diagnosis, differential diagnosis and the choice of therapeutic tactics to preserve the supporting function of the limb determine the difficulties in managing diabetic patients. Over the past decades, significant

Sodium-glucose cotransporter 2 inhibitors as potential anticancer agents

Oncological diseases are one of the leading causes of death in the world. Despite the intensive search for new methods to increase the effectiveness and safety of antitumor therapy and reduce resistance to it from malignant tumors, treatment issues still remain open in clinical oncology. This review analyzes experimental data indicating the antineoplastic effect of sodium-glucose cotransporter

Key stages of implementation and adaptation of digital infrastructure for medical care for patients with diabetic retinopathy in the Tomsk region

Digital screening for diabetic retinopathy (DR) is an effective measure recommended by WHO. To implement a modern digital screening program for DR, several important conditions must be met, while the organization of screening at the regional level requires a comprehensive approach that includes compliance with recommended international experience, taking into account the characteristics of the

Cardiodiabetology: Evolution or Revolution?

This article addresses contemporary issues in endocrine cardiology. The main content of the work is an analysis of the history of medications used in diabetology, ranging from the first animal-derived insulins to modern sodium-glucose cotransporter 2 inhibitors (SGLT2 inhibitors) and glucagon-like peptide-1 receptor agonists (GLP-1 RA), which possess pronounced cardioprotective activity. Studie

Diabetes Mellitus(ISSN:2072-0351)